The electrocardiogram provides crucial prognostic information in non-ST-segment elevation acute coronary syndromes, with ST-segment depression and lead aVR elevation strongly predicting poor outcomes and severe multivessel disease.
Does detailed electrocardiographic analysis improve risk stratification and diagnosis of severe coronary artery disease in patients with non-ST-segment elevation acute coronary syndromes?
Detailed ECG analysis, particularly evaluating quantitative ST-segment depression and ST-segment elevation in lead aVR, provides critical prognostic information and helps identify high-risk NSTE-ACS patients who may benefit from early invasive strategies.
In patients with non-ST-segment elevation acute coronary syndromes, early risk stratification is crucial for appropriate management of this condition and for deciding whether early invasive strategies should be adopted. The electrocardiogram (ECG) has been extensively used for risk stratification, and the presence of ST-segment depression is an especially strong predictor of poor outcomes. Furthermore, quantitative analysis of ST-segment depression, ie, the degree and extent of ST-segment depression, and the time from symptom onset to the evaluation of ECG provide important information on prognosis. ST-segment elevation in lead a V(R) in addition to ST-segment depression in other leads is a very valuable marker of left main and/or 3-vessel disease. This review explores the clinical importance of the ECG in the current interventional era.
Kosuge et al. (Thu,) conducted a review in Non-ST-Segment Elevation Acute Coronary Syndromes (NSTE-ACS). Electrocardiogram (ECG) was evaluated. The electrocardiogram provides crucial prognostic information in non-ST-segment elevation acute coronary syndromes, with ST-segment depression and lead aVR elevation strongly predicting poor outcomes and severe multivessel disease.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: